Courtesy of Greg Suh, University of California Los Angeles, Andrew Moore, InfrancoMoore Group
This developing eye from a chimeric Drosophila has wild-type tissue at the top and csn5 mutant tissue at the bottom causing disorganization. Overlaid is a schematic showing the predicted metalloprotease site of CSN5 cleaving an isopeptide bond.
It doesn't take a green thumb to predict what happens to plants left in the dark: They wither. But in the late 1980s and early 1990s, researchers, including people in Xing-Wang Deng's Yale University lab, stumbled upon a group of intriguing
In 1994, Deng's group identified
Deng and his lab were working explicitly on the signalosome, while Raymond Deshaies, a Howard Hughes Medical Institute assistant investigator at California Institute of Technology, was interested in identifying ubiquitin ligases and understanding their regulation in mammals and yeast. Deng says that he had immediately suspected that the COP9 signalosome he'd discovered was of some importance. But the enigmatic mutant phenotype offered few clues as to its function.
The first hint came in 1998. A German group4 and Deng's group5 both confirmed that mammals shared the same protein complex that had been discovered in plants. In the same year, another group, led by Harvard cell biologist Daniel Finley,6 discovered that the eight subunits of the CSN closely resemble a subcomplex of the proteasome, a veritable cellular trashcan that assists with protein degradation. This subcomplex, the so-called lid of the proteasome, appeared to play a key role in recognizing ubiquitin-tagged substrate proteins and channeling them for proteasomal degradation.
Courtesy of Giovanna Serino and Xing-Wang Deng
The subunit interaction relationship of the COP9 Signalosome (CSN) and its contact points with E3 ligase, SCF-TIR1.
Deng and colleagues provided more definitive details in 2000.7 One of Deng's students, Mark Osterlund, showed that the COP9 signalosome helps degrade the transcription factor HY5, a player in the light-regulated development of
Meanwhile, Deshaies, who was known primarily for his work on ubiquitin ligases in yeast, and erstwhile graduate student Lyapina sought to understand ubiquitin-ligase regulation in mammalian cells. They hunted proteins that copurified with the ubiquitin E3 ligase complexes, a specific type labeled SCF, to elucidate how the complex is regulated through its protein partners. To their surprise, they discovered that the SCF interacts with the signalosome.
Immediately there were two hypotheses, Lyapina explains: Either SCF ubiquitin ligase was somehow regulating the signalosome, or vice versa. In hopes of solving this puzzle, they contacted Deng to collaborate. Lyapina then set out to distinguish between these scenarios by attempting to downregulate the CSN and observe the consequences to SCF activity. She investigated the interaction in several model systems, but the breakthrough came in fission yeast,
Both Deshaies and Deng suggest that the two papers complement each other. "Ours is at the level of the molecules and his is at the level of the organism," Deshaies explains. Deng and colleagues, studying
Deshaies's lab demonstrated that the interaction of SCF and CSN also occurs in mammalian and yeast cells. Furthermore, they identified a particular biochemical modification: CSN regulates the ubiquitin ligase by cleaving a protein called NEDD-8 from a subunit of the SCF.
Deshaies emphasizes that signalosome knowledge, when Lyapina first started her work, was based largely on plant genetics. No biochemical assays were available, making targets hard to ascertain. But there was a wealth of biochemical knowledge about the SCF at the time of Lyapina's discovery, notes Deshaies. "So, she could kind of plug into that knowledge base to figure out what aspect of SCF was being modulated by signalosome."
Subsequent work from Deng's lab, Deshaies's lab, and others has illustrated the CSN's potential relevance for medical applications. Deshaies and graduate student Gregory Cope uncovered not only the ubiquitin connection but a metalloprotease correlation as well. Through a bioinformatics discovery that was later validated by a recently reported genetic analysis, Deshaies and Cope found that NEDD-8 cleavage occurred as a result of metalloprotease activity intrinsic to one of the signalo-some subunits.8 The opportunities for drug development were clear, says Lyapina. An enzymatic signalosome mechanism that's relevant to protein degradation and the cell cycle could be an early step toward developing therapies for a variety of diseases.
Many illnesses, especially cancer, notes Deng, stem from some defect in the cell's mechanism of protein degradation. In the two-plus years since the Hot Papers' publication, Deng's colleague, Yale cell biologist Ning Wei, has shown that CSN affects tumor suppressors p53 and p21, as well as other cell-cycle regulators. Wei's work included generating a mouse knockout of the CSN.9
But the 2001 papers continue to have implications for basic plant cell biology as well. A few months after the papers appeared, Mark Estelle, a professor of plant biology at Indiana University in Bloomington, discovered that auxin response requires an ubiquitin ligase.10 "It's become clear that ubiquitin-mediated processes are really important," says Estelle, who occasionally collaborates with Deng. "That hadn't been clear at all 10 years ago ... it's been a huge revelation."
Estelle contends that the ubiquitin connection was "the first clearly defined function that everyone could agree on, that everyone believed." But it was just the beginning, says Lyapina: "We sort of answered one question. But it opened up many more questions, so that people now could form hypotheses to test."
Data derived from the Science Watch/Hot Papers database and the Web of Science (ISI, Philadelphia) show that Hot Papers are cited 50 to 100 times more often than the average paper of the same type and age.